Komori
Business alliance3750ADR Biomedical Holdings Inc.Electricals and Precision Instruments

Notice Regarding the Launch of a New Business

The company will launch a new business in December 2026 to procure pharmaceuticals and medical supplies from manufacturers in Japan and overseas and sell them to medical institutions and clinics.

Worth reading
82Important
Scored from 2 of 5 sections
Direction
Improvement
Direction inferred from the company’s description.
Scale
350
¥ million (expected amount by which fiscal 2027 March revenue will be exceeded)
Wording
Conditional
How definitive the wording is.

Agreements reached under this partnership

Impact on Business Performance

For the fiscal year ending March 2027, revenue is expected to exceed the revenue in the medium-term plan by approximately ¥350 million. The impact on consolidated results is currently under review.

Date of board resolution18 November 2026Alliance start dateDecember 2026 (予定)
Agreements reached under this partnership
ItemDetails
Date of board resolution18 November 2026
Alliance start dateDecember 2026 (予定)
Impact on Business PerformanceFor the fiscal year ending March 2027, revenue is expected to exceed the revenue in the medium-term plan by approximately ¥350 million. The impact on consolidated results is currently under review.
Items this document does not state (20)
Name of alliance partnerAlliance partner's business activitiesAlliance partner's locationAlliance partner's capitalAlliance partner's net salesAlliance partner's operating incomeType of allianceDetails of the allianceNumber of shares acquiredAcquisition priceShareholding ratioOverview of the joint ventureOwnership ratioDispatch of directors and officersContract PeriodNumerical targets under the allianceShareholding PolicyContract DateShare Acquisition Date and Payment DateChange in major shareholders

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To expand revenue by leveraging business relationships with medical institutions, clinics and other customers built through its business activities to date.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Launch of a New Business | ADR Biomedical Holdings Inc. (3750) timely disclosure | Komori